These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24831310)

  • 21. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T; Otsuka M
    Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
    Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
    Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics simulation of amorphous indomethacin.
    Xiang TX; Anderson BD
    Mol Pharm; 2013 Jan; 10(1):102-14. PubMed ID: 23116319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
    Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
    Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase characterization of indomethacin in adsorbates onto hydroxyethylcellulose.
    Bogdanova S; Bontcheva E; Avramova N
    Drug Dev Ind Pharm; 2007 Aug; 33(8):900-6. PubMed ID: 17729108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
    Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
    Suzuki H; Iwata M; Ito M; Noguchi S
    Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
    Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
    Hurley D; Potter CB; Walker GM; Higginbotham CL
    J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.
    Ueda H; Aikawa S; Kashima Y; Kikuchi J; Ida Y; Tanino T; Kadota K; Tozuka Y
    J Pharm Sci; 2014 Sep; 103(9):2829-2838. PubMed ID: 24890320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of low molecular weight excipient octaacetylmaltose on the liquid crystalline ordering and molecular dynamics in the supercooled liquid and glassy state of itraconazole.
    Kaminska E; Tarnacka M; Kolodziejczyk K; Dulski M; Zakowiecki D; Hawelek L; Adrjanowicz K; Zych M; Garbacz G; Kaminski K
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1094-104. PubMed ID: 25460155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
    Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
    AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
    Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
    Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system.
    Yamamura S; Gotoh H; Sakamoto Y; Momose Y
    Eur J Pharm Biopharm; 2000 May; 49(3):259-65. PubMed ID: 10799818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in dynamics of the glass-forming pharmaceutical nifedipine in binary mixtures with octaacetylmaltose.
    Kaminska E; Tarnacka M; Kaminski K; Ngai KL; Paluch M
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):185-91. PubMed ID: 26428937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.